TAS4464: Clinical Trials

1 trial of TAS4464, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow TAS4464: new trials by email Literature Review of TAS4464 trials Research Report on TAS4464

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma
TAS4464 - Multiple Myeloma, NonHodgkin Lymphoma
Phase 1TerminatedTaiho Oncology, Inc.112017-03-012024-09-05

Conditions studied

Hematologic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell, Peripheral (1)  ·  Multiple Myeloma (1)  ·  Neoplasms (1)  ·  Neoplasms, Plasma Cell (1)  ·  Recurrence (1)

Sponsors

Taiho Oncology, Inc. (1)

Countries

United States (1)